...
首页> 外文期刊>ACS medicinal chemistry letters >Selective Inhibitors of Fibroblast Activation Protein (FAP) with a (4-Quinolinoyl)-glycyl-2-cyanopyrrolidine Scaffold
【24h】

Selective Inhibitors of Fibroblast Activation Protein (FAP) with a (4-Quinolinoyl)-glycyl-2-cyanopyrrolidine Scaffold

机译:具有(4-Quinolinoyl)-glycyl-2-cyanopyrrolidine支架的成纤维细胞活化蛋白(FAP)的选择性抑制剂

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Fibroblast activation protein (FAP) is a serine protease that is generally accepted to play an important role in tumor growth and other diseases involving tissue remodeling. Currently there are no FAP inhibitors with reported selectivity toward both the closely related dipeptidyl peptidases (DPPs) and prolyl oligopeptidase (PREP). We present the discovery of a new class of FAP inhibitors with a N-(4-quinolinoyl)-Gly-(2-cyanopyrrolidine) scaffold. We have explored the effects of substituting the quinoline ring and varying the position of its sp2 hybridized nitrogen atom. The most promising inhibitors combined low nanomolar FAP inhibition and high selectivity indices (>103) with respect to both the DPPs and PREP. Preliminary experiments on a representative inhibitor demonstrate that plasma stability, kinetic solubility, and log D of this class of compounds can be expected to be satisfactory.
机译:成纤维细胞活化蛋白(FAP)是一种丝氨酸蛋白酶,通常被认为在肿瘤生长和其他涉及组织重塑的疾病中起重要作用。目前,尚无FAP抑制剂对紧密相关的二肽基肽酶(DPPs)和脯氨酰寡肽酶(PREP)具有选择性。我们目前与N-(4-喹啉基)-Gly-(2-氰基吡咯烷)支架的新型FAP抑制剂的发现。我们已经探索了取代喹啉环并改变其sp2杂化氮原子位置的影响。对于DPP和PREP,最有前途的抑制剂结合了低纳摩尔FAP抑制和高选择性指数(> 103)。在代表性抑制剂上的初步实验表明,此类化合物的血浆稳定性,动力学溶解度和log D可望令人满意。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号